We studied hue discrimination and brightness matching throughout the spectrum in ten juvenile patients suffering from diabetes mellitus (Type I) with no (eight patients) or mild (two patients) retinopathy. In addition, the FM 100-Hue test was performed. The data were collected once every year over 5 years. Over the 5 years, the diabetics show a continual change in the shape of their brightness matching function. Wavelength discrimination ability remains quite stable with time at the long end of the spectrum but is variable at short wavelengths. FM-100 error scores remain similar over the period tested, at a level slightly higher than that of a control group. Additional experiments show that the sensitivity of the S-cone in the diabetic group is similar to that of controls. The results can be explained by an early relative reduction in the sensitivity of post-receptoral processes in juvenile diabetics.
Introduction
Elevated blood glucose levels in patients suffering from diabetes lead to retinal vascular changes, anoxia and cell death. The development of a retinopathy denotes that the vascular changes are clinically apparent in the retina, but changes in the metabolism of the diabetic eye occur before an alteration of the fundus (Cunha-Vaz, Faria de Abreu, Campos & Figo, 1975; Greene, Lattimer & Sima, 1987; Tehrani, Yamamoto & Garner, 1990; Gonzalez Flecha, Bermudez, Cédola, Gagliardino & Rossi, 1990) . Anoxia and decreased metabolic activity cause changes in the membrane equilibrium potential, producing a scaling down of the response of retinal cells and can depress the visual system's sensitivity to light (Greenstein, Hood & Campbell, 1982; . This can be seen in dark-adaptation measurements in some diabetics with and without visible retinopathy, who have been shown to have higher thresholds than normal or take longer to adapt (Henson & North, 1979) . But the most widely reported early visual deficits in diabetics are those of the Tritan type, involving a loss in sensitivity at the short wavelength end of the spectrum as measured by hue discrimination or spectral thresholds Marré & Marré, 1972; /1973 Zwas, Wiess & McKinnon, 1980; Zisman & Adams, 1982; Greene, Ghafour & Allan, 1985; Roy, Gunkel & Podgor, 1986; Trick, Burde, Gordon, Santiago & Kilo, 1988; Peduzzi, Longanesi, Ascari, Cascione, Galletti, Roncaia, Pacchioni & Maione, 1989; Greenstein, Sarter, Hood, Noble & Carr, 1990; Kurtenbach, Wagner, Neu, Schiefer, Ranke & Zrenner, 1994; Kurtenbach, Rü ttiger, Schiefer, Zrenner & Neu, 1995) . In considering the short wavelength deficit, it has been stressed by several authors that the different response ranges of the cones, along with differential adaptation can make the S-pathway appear more vulnerable to retinal disease (Hood, Benimoff & Greenstein, 1984; Greenstein, Hood, Ritch, Steinberger & Carr, 1989; Kalloniatis & Harwerth, 1989 Greenstein, Shapiro, Zaidi & Hood, 1992) .
The sensitivity loss may be caused by changes at several sites. At the preretinal level diabetics show an accelerated yellowing of the lens (Lutze & Bresnick, 1991) , which causes a filtering of short wavelength light. Retinal function is also impaired. A priori, one may expect early changes of inner retina function, due to a disturbance of retinal circulation. Indeed the opponent system between the short (S) and long and middle wavelength sensitive cones (L +M) has been shown to manifest early changes in sensitivity in patients with retinopathy, at or beyond the inner retinal sites of chromatic opponency (Schefrin, Adams & Werner, 1991; Greenstein, Shapiro, Zaidi & Hood, 1992) . These studies ruled out a receptor contribution to the deficit. On the other hand, reduced diffusion of oxygen from the outer retina to supply ischemic inner retinal layers, could cause receptor malfunction (Flower & Patz, 1971) . Elsner, Burns, Lobes & Doft (1987) have found abnormalities in the photopigment bleaching of long (L) and middle (M) wavelength sensitive cones in some diabetics with and without retinopathy. Short wavelength sensitive cones were not tested.
The study of diabetic patients is complicated by a considerable interindividual variability. Blood sugar level and duration of disease are important factors for the development of a retinopathy, but in many cases there is no significant correlation between them /1973 Greenstein, Sarter, Hood, Noble & Carr, 1990) . Similarly, decreases in sensitivity in most reports are not significantly correlated to the degree of retinopathy. Results may be confounded by the blood glucose level at the time of testing, which have recently been shown to cause a transient decrease in S-pathway sensitivity (Volbrecht, Schneck, Adams, Linfoot & Ai, 1994 ) and contrast sensitivity in some patients (Mangouritsas, Katoulis, Kepaptsoglou & Zoupas, 1995) . Recent results using the desaturated D-15 panel test (North, Cooney, Chambers, Dolbern & Owens, 1997) , on the other hand, show no correlation between increases in plasma glucose and colour vision in diabetics. Despite this variability between individuals, high blood sugar levels and a long duration of diabetes are most likely to lead to sensitivity and fundus changes.
The purpose of this experiment was to study the development of the early sensitivity and colour deficit in diabetics. We have reported the initial results for 20 juvenile patients (Kurtenbach, Wagner, Neu, Schiefer, Ranke & Zrenner, 1994) . For ten of these patients we monitored the average results in a yearly examination over a 5 year period. The remaining ten patients either did not wish to continue in the study or had moved from the area. Juveniles seldom show signs of vascular alteration before puberty, and so this period of hormone change reflects a critical time in the development of a retinopathy / 1973 Klein, Klein & Moss, 1989) . Each year the subjects underwent an ophthalmological examination and we tested pyschophysically, brightness matching and wavelength discrimination throughout the spectrum, as well as administering the Farnsworth-Munsell 100-Hue Test (FM-100), a clinical panel test of hue discrimination. The results obtained after 1 year in 20 subjects (Kurtenbach, Wagner, Neu, Schiefer, Ranke & Zrenner, 1994) and after 3 years in ten patients (Kurtenbach, Rü ttiger, Schiefer, Zrenner & Neu, 1995) showed changes in brightness and colour perception. The results to be reported here show that the most prominent changes after 5 years are to be found in the perception of brightness.
Method

Subjects
Ten insulin dependent volunteers, suffering from diabetes mellitus (Type I) were studied. They were aged between 11 and 18 years (mean 9 1 SD: 14.349 2.24; median 14.3) at the first year of testing and had had diabetes for between 4 and 12 years (mean 7.919 3.26; median 7.2). They were recruited from the Children's Hospital, Tü bingen which they had attended on average every 8-10 weeks since the onset of the disease for control examinations. The metabolic values used in this study were taken within 94 weeks of the psychophysical testing. The average yearly values for creatinine, i2-microglobulin and urea remained below population recommended values, those for cholesterin and triglyceride varied around the upper population limit. Only the average blood glucose level (measured by glycosylated haemoglobin, gHb) was raised above the normal limit. Over the 5 years, this average value dropped from 11.38% (9 3.16; median 9.6) in the first year of testing to 9.57% (9 1.46; median 9.31) in the last, and varied between 7.5 and an unusually extreme value of 18%. Eight of the subjects showed no signs of vascular changes in the retina. The two oldest subjects, who had had diabetes for over 12 and 9 years, both showed signs of a few microaneurisms (Bresnick stage 2) at the start of the experiment. Over the period tested, the number of microaneurisms sporadically changed, but the retinopathy remained at this stage of development. Lens changes were not detectable with slit lamp examination, and visual acuity and intraocular pressure were normal.
The colour vision of the diabetic group (ten patients in years 1, 3, and 5; nine patients in years 2 and 4), was compared to those of a control group of 20 healthy subjects aged between 11 and 22 years (mean 17.89 3.3). They were admitted to the study if their colour vision, as tested with the FM-100 test, and visual acuity were normal. Fundus examination or photography was not carried out. The full control group was tested in the first year only. At the end of the 4th year, six of them were retested.
Method and procedure
Subjects first underwent an ophthalmological examination with visual acuity measurements and then performed the psychophysical tests, outlined below. Finally intraocular pressure was measured and the fundus was examined (direct and indirect ophthalmoscopy) and photographed.
The psychophysical tests, which were performed monocularly, consisted of the FM-100, measured under standardised procedures (colour temperature 6000 K; 1500 lux), heterochromatic brightness matching (HBM) and wavelength discrimination. The latter two were performed using a computer driven three channel Maxwellian view system (Reitner, Sharpe & Zrenner, 1992) . Subjects monocularly viewed a 2°circular bipartite field, separated by a 5 min arc black line. Their head was held steady with a chin and head rest. The subjects were instructed to match in brightness each wavelength presented in the left hemifield, with a 540 nm, 8.5 log Q/s per deg 2 (260 td) reference hemifield presented to the right hemifield. Brightness matching was measured in 10 nm steps from 420 to 680 nm. An ascending and descending method of limits was used, and the mean of 4 measurements calculated for each data point. An equally bright homogeneous adaptation field (6000 K) was presented for 20 s between each wavelength presentation, to maintain a uniform adaptation level. These equal brightness matches were then used for the subsequent wavelength discrimination experiment performed between 440 and 640 nm in steps of 20 nm, carried out without further readjustment for equal brightness. The bipartite field was presented for 1 s between an adaptation field presentation of 5 s, after which the subject indicated whether he had perceived a difference in hue between the two hemifields. Wavelength was varied in 1 nm steps. An ascending method of limits was used to find the just noticeable difference (delta lambda) for main wavelengths. Five measurements were taken: the first was discarded and the mean of the remaining four used to determine each data point. One experimental session lasted on average about 2 h.
Results
In Fig. 1 , we have plotted the results of heterochromatic brightness matching to a standard of 540 nm, 260 td. Log relative sensitivity, calculated from the inverse of the matched luminance, is plotted against the wavelength. The curves have been displaced on the Y-axis for clarity. The uppermost curve shows the mean results of the control group of 20 subjects in the first year of testing. The hairline shows the mean results of the six subjects repeated after 4 years. The open circles show the mean results obtained from the diabetic group for each year of testing. Over the years, the HBM curve in the diabetic group alters its shape. The curve becomes shallower, extending around 1.3 log units in depth for the first year of testing, and 1.1 log unit in the 5th year. The average standard errors (see Fig. 4 ) are around 0.1 log unit, showing that the shape of curve differs considerably between individual subjects. The average standard deviation within the results of one subject, however, was around 0.05 log units. There was no significant correlation between the gHb levels and the sensitivity at 570 or 460 nm (least squares linear regression). delta lambda values at 440 and 460 nm (paired t-test) . There was also no significant correlation between gHb and the delta lambda value at 460 nm.
The results of the FM-100 panel test ( + 1 SD) can be seen in Fig. 3 , for the control and the diabetic groups over the 5 years. Because the distribution of error scores is skewed, the square root of the error score is shown, which follows a normal distribution (Kinnear, 1970) .
The total error score (upper panel) has been divided into two groups representing the errors in the red-green quadrants (caps 14-34, 56-76, middle panel) and the blue-yellow quadrants (caps 1-13, 35-55, 77-85, lower panel) of the colour circle. It is notable that the first year of testing, for both groups, yielded substantially higher scores than the subsequent years. All mean diabetic total scores are below the normal limit for this age group. In the first year of testing their results are higher than those of the control group and in the 4 The results we obtained from the wavelength discrimination task can be seen in Fig. 2 , where the just noticeable difference in wavelength (delta lambda) is plotted against the wavelength for each year of testing. The results from the control group are shown by the continuous thick line (91 SE). The repeat control group of six subjects is again shown by the hairline. At the extreme ends of the spectrum, the values deviate somewhat from the original results. For the diabetic group, the results over the 5 years show some variability. The first year shows in general a higher delta lambda, except in the short wavelength spectral region. For the following years, the curve, at least in the long wavelength region, returns to near control level. At the short wavelength end of the spectrum, the results are much more variable. In the second and third years, there is a pronounced, though not significant rise in subsequent years their results remain relatively constant, but with more errors than the repeat control group. In the first year of testing, the B/Y scores of the diabetics are significantly different from those of the controls (PB0.05, unpaired t-test). There is no significant correlation between the FM-100 scores and gHb levels (least squares linear regression).
Discussion
Heterochromatic Brightness Matching
The HBM results (Fig. 1) show progressive changes in sensitivity over the 5 years in the diabetic group. HBM curves, unlike spectral threshold measurements, give no information about the absolute sensitivity, i. e. how bright or dark the comparison field appears for individual subjects, and all curves necessarily come together here at 540 nm, the comparison wavelength. The diabetic curves thus show a relative increased sensitivity at short and long wavelengths in comparison to the control curve. To try to characterise the changes seen in the diabetic groups, we first compare our results to the CIE (1978) HBM function for the standard observer. In Fig. 4 (upper panel) , we show the mean results for our control group ( 91 SE) in comparison to the CIE function (thick continuous line). The hairline shows the mean values for the six control subjects repeated in year 4. To gain information about absolute sensitivity, we slid the experimental curve along the Y-axis to obtain maximum overlap with the HBM function, the assumptions being that the curves are thus optimally positioned, and that the most sensitive mechanism responds and will dominate in the curves (Lee & Martin, 1989; Sperling, 1993) . The control data points found in this experiment lie very close to the CIE function, except in the region around 540 nm, the wavelength of the comparison field. The lower panel in Fig. 4 shows the mean results of the juvenile diabetic group for years 1, 3 and 5 in comparison to the CIE function. Using this method of presentation, the diabetic group show a decrease in sensitivity between 500 and 600 nm for year 1, spreading to between 440 and 630 nm for year 5. It is thus probable that the juvenile diabetics exhibit a relative reduction of sensitivity at middle wavelengths, compared to short and long wavelengths.
The shape of the HBM function is thought to be determined by opponent colour mechanisms, formed by the subtractive interaction of cone responses, as well as the non-opponent achromatic channel (Guth & Lodge, 1973; Ingling & Tsou, 1977; Yaguchi & Ikeda, 1982; Nakano, Ikeda & Kaiser, 1988; Kalloniatis & Pianta, 1997) . We used the Smith & Pokorny (1975) cone fundamentals to calculate opponent functions. Interac- tion coefficients were the mean of those calculated by Nakano, Ikeda & Kaiser (1988) from the brightness matching results of ten subjects, i.e.
The opponent pathways thus calculated can be seen compared to our control results in the upper panel of Fig. 5 (continuous lines) . Individual mechanisms were again shifted on the Y-axis to provide maximum overlap. Together they provide a reasonable fit to our control curve for most of the spectrum. Sensitivity at the short wavelength end of the spectrum is low. This is due to the relatively low luminance (260 td) used in this experiment: the long and middle wavelength sensitive pathways will be more sensitive to luminance changes than the short wavelength sensitive pathway (Sperling & Harwerth, 1971; Yeh, Smith & Pokorny, 1989; Kalloniatis & Harwerth, 1990) . For comparison purposes only, we have indicated the sensitivity of the S-cone mechanism and of the non-opponent channel (calculated following Kalloniatis & Pianta, 1997 ; L+ 2.72 M), with discontinuous lines in Fig. 5 .
In the lower panel of Fig. 5 , we have plotted the diabetic results in the last year of testing, compared to these opponent and non-opponent functions and the short wavelength cone mechanism. The results of the juvenile diabetics can be explained by a relative reduction either in the sensitivity of the opponent M-L pathway or the non-opponent channel, or both. At the short wavelength end of the spectrum, the S-cone mechanism appears to be more prominent in the diabetic curve compared to the control results.
To study further the sensitivity changes at the short end of the spectrum, we performed one additional experiment, year 6 after the start of the study. Here we reduced the purity of the stimulus to 0.26 by superimposition of a bright white background field. This procedure, at least in the spectral region between 540 and 600 nm, produces HBM curves very similar to threshold spectral sensitivity curves, with pronounced opponent mechanisms, most probably due to adaptation of the non-opponent pathway (Kurtenbach, Rü ttiger, Kaiser & Zrenner, 1997) . Brightness matching was made in this case against a white comparison hemifield of 260 td. The mean results can be seen in Fig. 6 , where the results from the same diabetic group (open symbols) are compared to those from a new age-matched control group of ten subjects (solid symbols), aged between 16 and 25 (mean 19.069 3.16). Error bars indicate 91 SE. The continuous lines depict opponent mechanisms, here based on spectral sensitivity threshold measurements. The peaks of the spectral sensitivities of the cone fundamentals (Smith & Pokorny, 1975) were normalised to 1 on an energy basis at the cornea. We then used an interaction factor of 1.35, the average found for five observers by Calkins, Thornton & Pugh (1992) to calculate the antagonistic processes, i.e.:
At the short wavelength end of the spectrum, we again show the S-cone sensitivity with a discontinuous line. The results are quite similar with no significant differences, although the diabetics are slightly lower in sensitivity for both opponent mechanisms. As with threshold spectral sensitivity measurements, this method gives data points at the short wavelength end of the spectrum that are well-fit by the sensitivity of the S-cone.
The data points from the diabetic group in Fig. 6 are very similar to those of the controls, indicating that the S-cone sensitivity is unaltered in these juvenile diabetics. Lutze & Bresnick (1991) have shown that diabetics in this age group may be around 0.2 log units less sensitive at the short wavelengths, due to premature ageing of the lens. This may not be detected by slitlamp ophthalmoscopy used in this study to assess the lens opacity, but the similarity of the curves at the short wavelength end of the spectrum indicate that lens changes do not play a significant role in these results.
Wa6elength discrimination
The shape of the wavelength discrimination curve for the control group (Fig. 2) resembles the classical discrimination data of Laurens & Hamilton (1923) and Wright & Pitt (1934) . We find higher values due to the method used. The diabetic group shows no continuous trend over the 5 years. In the first year of testing there is a general increase in delta lambda, which is not stable, so that after 5 years, the curves are more similar to those of the controls and show better discrimination than in the first year. Two factors may contribute to an increase in discriminability over the years: Firstly, there may be a learning effect. Secondly, it is possible that the discrimination ability increases with age in juveniles, as shown by Verriest (1963) for the FM-100 test (see below).
The task of hue discrimination depends on opponent interactions between receptors and is limited by the rate of change with wavelength of the ratio of quantum catches (L/M and S/L or S/M) and by the dynamic range of post-receptoral channels. The shape of the wavelength discrimination curve is most likely determined by the L/M ratio throughout the majority of the spectrum and only the region between 460 and 520 nm is thought to reflect the activity of the S/L (or S/M) mechanisms (Mollon & Jordan, 1988 Mollon, Estévez & Cavonius, 1991) . Our diabetic function is most constant at the long wavelength end of the spectrum indicating little change in the L/M ratio. At the short end of the spectrum the results are much more variable. This variability of the S-pathway sensitivity may reflect the acute blood glucose levels at the time of testing, which have been shown to affect the short wavelength pathway sensitivity (Volbrecht, Schneck, Adams, Linfoot & Ai, 1994) .
Farnsworth-Munsell 100-Hue test
The FM-100 is also a test of hue discrimination. The results (Fig. 3) show a stable error score in the diabetic group over the years, apart from the error score obtained in the first year. The control group also shows a large decrease in error score at the second testing. This can be explained by a learning effect: Verriest, Van Laethem & Uvijls (1982) have reported a significant decrease of monocular test scores on retesting with the FM-100 for this age group. In addition, the average FM-100 error score decreases with age until around 20 -29 years (Verriest, 1963) . Due to the age of our subjects (mean 14.34 years at the start of the experiment) some decrease in error score over the years may be expected.
Diabetics with retinopathy are known to show Tritan errors with the FM-100, as well as a reduced discriminability throughout the spectrum (Birch & Dain, 1987) . Our results with juvenile diabetics also show a slightly reduced hue discriminability throughout the spectrum, and for the first year of testing only, significantly higher B/Y scores than the control group, although the error scores are still within those of the normal population. Similar results have previously been reported by Roy, Gunkel & Podgor (1986) and Trick, Burde, Gordon, Santiago & Kilo (1988) . We also confirm the tendency for a higher blue-yellow partial error score compared to red-green score for both control and diabetic groups for this test as found by Trick, Burde, Gordon, Santiago & Kilo (1988) and Greenstein, Shapiro, Zaidi & Hood (1990) . The reason for this lies in the colour differences between adjacent caps: adjacent caps in the blue quadrant show smaller colour differences than those in other quadrants, causing it to be more difficult (Lakowski, 1969) .
Conclusion
The deficit we find in these juvenile patients is not generally of the Tritan type. On the contrary, we have shown that their S-cone sensitivity is normal (Fig. 6) . We also find no evidence for defects of either M or L cone, which would be apparent as an relative increase in error scores in the R-G quadrants of the FM-100 test, or larger delta lambda values at middle and long wavelengths in the wavelength discrimination experiment. The results of anomaloscope matches for a larger group of 17 juvenile diabetics, including the ten studied here, are in agreement with these findings (Kurtenbach, Schiefer, Zrenner & Neu, 1997) .
The deficit shown in HBM curves from juvenile diabetics is explicable by a relative reduction in functions affecting the central spectral regions, post receptoral opponent or non-opponent channels. Malfunction at the postreceptoral level of the retina may also explain the reduced discrimination ability throughout the spectrum seen in the FM-100 test error scores.
The results of both hue discrimination experiments (FM-100 and wavelength discrimination) although differing widely in ease of accomplishment for the subjects, both show better performance at year 5 than year 1, indicative of learning or age effects for both these tasks. Volbrecht, Schneck, Adams, Linfoot & Ai (1994) and Mangouritsas, Katoulis, Kepaptsoglou & Zoupas (1995) have shown that increases in blood sugar level lead to immediate transient changes in sensitivity. This may have some influence on the wavelength discrimination and FM-100 results. But on the results of the HBM, it can have little effect, as we find a progressive decrease in sensitivity, despite a generally better control of the disease by the subjects. The changes found in the HBM curve may thus reflect the chronic changes in the diabetic eye.
